117 results
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
is not aware of any existing or imminent labor dispute with the employees of any principal supplier, manufacturer, customer or contractor of the Company
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
28 May 21
Entry into a Material Definitive Agreement
5:03pm
existing or imminent labor dispute with the employees of any principal supplier, manufacturer, customer or contractor of the Company.
(u) Intellectual
424B3
ONCT
Oncternal Therapeutics Inc
8 May 19
Prospectus supplement
12:00am
to obtain approval from the FDA of an alternate supplier, would delay or prevent the clinical development and commercialization of any potential … , including safety data reports, and collaborate with the clinical supplier in relation to any interactions with regulatory authorities regarding ibrutinib
S-4/A
e9cwv0v 6kio639
3 May 19
Registration of securities issued in business combination transactions (amended)
9:51pm
S-4
EX-10.64
3syf4 x00dtvlji2tr7o
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
EX-10.65
4f55g5bn9iev7tomem
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
EX-10.54
f8aka08ezf0zbw6
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
qsyx1sisox4ysluc0x
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm